Modafinil is a non-stimulant medication used to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder (SWD). In the United States, it is marketed with the name Provigil.
Evidence[edit | edit source]
Notable studies[edit | edit source]
- 2000, Effect of Modafinil on Fatigue Associated with Neurological Illnesses
References[edit | edit source]
- "Medication Guide" (PDF). U.S. Food & Drug Administration. Retrieved Jun 15, 2019.
- Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey A.; van de Sande, Marjorie I. (2003), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols" (PDF), Journal of Chronic Fatigue Syndrome, 11 (2): 7-115, doi:10.1300/J092v11n01_02
- Cochran, John W. (2000). "Effect of Modafinil on Fatigue Associated with Neurological Illnesses". Journal of Chronic Fatigue Syndrome. 8 (2): 65–70. doi:10.1300/J092v08n02_06. ISSN 1057-3321.
chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.